tiprankstipranks
Instil Bio (TIL)
NASDAQ:TIL
US Market

Instil Bio (TIL) Financial Statements

Compare
349 Followers

Instil Bio Financial Overview

Instil Bio's market cap is currently $131.17M. The company's EPS TTM is $-11.555; its P/E ratio is ―; Instil Bio is scheduled to report earnings on March 10, 2025, and the estimated EPS forecast is $-3.22. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 138.00K$ 0.00
Gross Profit$ -4.76M$ -5.99M$ -2.75M$ 138.00K$ -20.00K
Operating Income$ -90.54M$ -226.46M$ -155.56M$ -33.64M$ -6.58M
EBITDA$ -146.12M$ -217.38M$ -154.00M$ -33.39M$ -6.50M
Net Income$ -156.09M$ -223.18M$ -156.79M$ -37.74M$ -6.45M
Balance Sheet
Cash & Short-Term Investments$ 150.36M$ 260.92M$ 454.10M$ 241.71M$ 8.89M
Total Assets$ 325.63M$ 482.13M$ 609.98M$ 319.01M$ 9.48M
Total Debt$ 86.05M$ 79.90M$ 0.00$ 0.00$ 0.00
Net Debt$ 76.86M$ 36.19M$ -37.59M$ -241.71M$ -8.89M
Total Liabilities$ 99.80M$ 118.52M$ 54.78M$ 358.61M$ 16.37M
Stockholders' Equity$ 225.83M$ 363.61M$ 555.20M$ -39.60M$ -6.89M
Cash Flow
Free Cash Flow$ -102.69M$ -264.75M$ -179.97M$ -80.43M$ -6.05M
Operating Cash Flow$ -82.03M$ -180.16M$ -122.14M$ -29.62M$ -5.29M
Investing Cash Flow$ 41.13M$ 114.54M$ -474.40M$ -51.12M$ -760.00K
Financing Cash Flow$ 8.08M$ 71.89M$ 393.16M$ 313.05M$ 14.95M
Currency in USD

Instil Bio Earnings and Revenue History

Instil Bio Debt to Assets

Instil Bio Cash Flow

Instil Bio Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis